Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Unlocking human potential with breakthrough mammary biotechnology.
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.
Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.
Entasis Therapeutics is developing a portfolio of innovative cures.
BioPhero is a pioneer in providing low-cost bio-based pheromones for pest management.
ZELP aims to significantly reduce the environmental impact of the livestock industry.
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Stargazer Pharmaceuticals offers the therapy of standards disorder and manufacturer of pharmaceuticals products.
Syndesi Therapeutics develops a drug candidate for the treatment of consecutive cognitive disorders of various neurological conditions.
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.
AFYX Therapeutics is a clinical stage biopharmaceutical company
Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Outpost Medicine is a biopharmaceutical company
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
Amra uses cloud-based, computer aided service to analytically transform MR images into body composition measurements.
Macrophage Pharma is a immune-oncology company
Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer.
Novo Holdings has invested in 216 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 19 different industry categories.
Among tracked funding rounds, Hummingbird Bioscience received $125.0M in a Series C round. Novo Holdings's total known invested capital is $15.2B.
Novo Holdings's average investment size is $84.4M across its portfolio of 216 companies.
Recent Novo Holdings portfolio additions include BIOMILQ, Tarveda Therapeutics, Aristea Therapeutics, NeRRe Therapeutics, Bolt Biotherapeutics. These companies were founded in 2020 or later.